Company profile: Singleron
1.1 - Company Overview
Company description
- Provider of clinical diagnosis, health management, and drug development products and services, dedicated to applying single cell analysis techniques. Holds a worldwide exclusive IP license from Yale University for a uniquely designed microfluidic single cell processing device.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Singleron
Purigen Biosystems
HQ: United States
Website
- Description: Provider of automated solutions for DNA and RNA purification using a proprietary approach with isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface; technology is agnostic to nucleic acid size or sequence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Purigen Biosystems company profile →
Evonetix
HQ: United Kingdom
Website
- Description: Provider of a benchtop platform that synthesizes, assembles, and error-corrects gene-length DNA on a silicon chip with unprecedented accuracy and scale using thermal control of DNA synthesis. Offers chip technology to synthesize thousands of oligonucleotide sequences simultaneously, binary assembly, and thermal error removal for rapid, precise gene synthesis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evonetix company profile →
Azitra
HQ: United States
Website
- Description: Provider of microbiome-based dermatology therapeutics and consumer products, offering bioengineered live biotherapeutic candidates ATR-12 for Netherton syndrome, ATR-04 for EGFR inhibitor-associated rash, and protein candidate ATR-01 for ichthyosis vulgaris; and a microbiome dermatology platform to develop products for skin disease treatment and skin appearance improvement; plus topical ointments and creams for dryness, redness, flakiness, and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Azitra company profile →
Smart Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development focused on orally administered drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Smart Therapeutics company profile →
Forma Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical discovery, development and commercialization of transformative medicines leveraging biology and chemistry to address genomically validated cancer drivers; haemophilia A prophylaxis with Mim8 and the FRONTIER clinical programme; diabetes care for children; low-cost insulin access; humanitarian health partnerships; and haemophilia care support via a dedicated foundation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forma Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Singleron
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Singleron
2.2 - Growth funds investing in similar companies to Singleron
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Singleron
4.2 - Public trading comparable groups for Singleron
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →